Cargando…

Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review

Introduction: Extensive research has made it possible to conclude that dysfunctions in serotoninergic transmission are associated with a tendency toward violence and behavioral dysregulations in humans. In this regard, it has been suggested that selective serotonin reuptake inhibitors (SSRIs), such...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Martínez, Ángel, Murciano-Martí, Sonia, Moya-Albiol, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562745/
https://www.ncbi.nlm.nih.gov/pubmed/31126061
http://dx.doi.org/10.3390/bs9050057
_version_ 1783426373479563264
author Romero-Martínez, Ángel
Murciano-Martí, Sonia
Moya-Albiol, Luis
author_facet Romero-Martínez, Ángel
Murciano-Martí, Sonia
Moya-Albiol, Luis
author_sort Romero-Martínez, Ángel
collection PubMed
description Introduction: Extensive research has made it possible to conclude that dysfunctions in serotoninergic transmission are associated with a tendency toward violence and behavioral dysregulations in humans. In this regard, it has been suggested that selective serotonin reuptake inhibitors (SSRIs), such as sertraline, which regulate the serotonin system, might reduce proneness to violence. Aims: This review aims to explore changes in feelings of anger-state (e.g., irritability and hostility) and anger expression as primary outcomes after sertraline treatment. Methods: Based on PRISMA quality criteria for reviews, a literature search was carried out through PubMed, PsycINFO, Dialnet, Psicodoc, Web of Knowledge, and the Cochrane Library. Results: Initially, 605 publications were identified, removing 219 duplicate manuscripts and screening the titles and abstracts of the remaining 386 records. This process left 248 articles for full-text reading, finally including 15 entries. Thus, several empirical studies were included that employed different research designs. In this regard, we considered 3 case reports, 5 open clinical trials, and 7 randomized placebo-controlled trials. The majority of the studies were unanimous in concluding that a large percentage of patients with high irritability levels responded satisfactorily to sertraline treatment. In fact, their mood improved, and they experienced a reduction in irritability and anger expression after a few weeks of treatment (approximately two weeks). However, it was necessary to increase the sertraline dose after months of treatment to avoid exhaustion effects. Moreover, not all the patients responded to the treatment and it is particularly interesting that a small percentage of patients were refractory to treatment or even showed an increase in irritability after a few weeks of treatment. In those cases, it was necessary to discontinue the treatment or reduce the dose to the initial levels. Discussion: Although it is necessary to be cautious about the benefits of sertraline as a way to control anger and irritability, it is relevant to consider pharmacological strategies to reduce anger-state as coadjutant treatments to psychotherapy in order to promote lasting changes in violent populations.
format Online
Article
Text
id pubmed-6562745
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65627452019-06-17 Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review Romero-Martínez, Ángel Murciano-Martí, Sonia Moya-Albiol, Luis Behav Sci (Basel) Review Introduction: Extensive research has made it possible to conclude that dysfunctions in serotoninergic transmission are associated with a tendency toward violence and behavioral dysregulations in humans. In this regard, it has been suggested that selective serotonin reuptake inhibitors (SSRIs), such as sertraline, which regulate the serotonin system, might reduce proneness to violence. Aims: This review aims to explore changes in feelings of anger-state (e.g., irritability and hostility) and anger expression as primary outcomes after sertraline treatment. Methods: Based on PRISMA quality criteria for reviews, a literature search was carried out through PubMed, PsycINFO, Dialnet, Psicodoc, Web of Knowledge, and the Cochrane Library. Results: Initially, 605 publications were identified, removing 219 duplicate manuscripts and screening the titles and abstracts of the remaining 386 records. This process left 248 articles for full-text reading, finally including 15 entries. Thus, several empirical studies were included that employed different research designs. In this regard, we considered 3 case reports, 5 open clinical trials, and 7 randomized placebo-controlled trials. The majority of the studies were unanimous in concluding that a large percentage of patients with high irritability levels responded satisfactorily to sertraline treatment. In fact, their mood improved, and they experienced a reduction in irritability and anger expression after a few weeks of treatment (approximately two weeks). However, it was necessary to increase the sertraline dose after months of treatment to avoid exhaustion effects. Moreover, not all the patients responded to the treatment and it is particularly interesting that a small percentage of patients were refractory to treatment or even showed an increase in irritability after a few weeks of treatment. In those cases, it was necessary to discontinue the treatment or reduce the dose to the initial levels. Discussion: Although it is necessary to be cautious about the benefits of sertraline as a way to control anger and irritability, it is relevant to consider pharmacological strategies to reduce anger-state as coadjutant treatments to psychotherapy in order to promote lasting changes in violent populations. MDPI 2019-05-23 /pmc/articles/PMC6562745/ /pubmed/31126061 http://dx.doi.org/10.3390/bs9050057 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Romero-Martínez, Ángel
Murciano-Martí, Sonia
Moya-Albiol, Luis
Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title_full Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title_fullStr Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title_full_unstemmed Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title_short Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review
title_sort is sertraline a good pharmacological strategy to control anger? results of a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562745/
https://www.ncbi.nlm.nih.gov/pubmed/31126061
http://dx.doi.org/10.3390/bs9050057
work_keys_str_mv AT romeromartinezangel issertralineagoodpharmacologicalstrategytocontrolangerresultsofasystematicreview
AT murcianomartisonia issertralineagoodpharmacologicalstrategytocontrolangerresultsofasystematicreview
AT moyaalbiolluis issertralineagoodpharmacologicalstrategytocontrolangerresultsofasystematicreview